Eli Lilly & Co. vs. Rhythm Pharmaceuticals, Inc. Common Stock
LLY
Eli Lilly & Co.
$1164.89 +1.04%
VS RYTMRhythm Pharmaceuticals, Inc. Common Stock
$104.71 +2.46%
Eli Lilly & Co. (LLY) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| LLY | RYTM | |
|---|---|---|
| Market Cap | $1.03 trillion | $7.21 billion |
| Revenue (TTM) | $79.67 billion | $239.92 million |
| Net Income (TTM) | $26.71 billion | $-205,346,000 |
LLY leads on 3 of 3 size & scale factors.
Valuation
| LLY | RYTM | |
|---|---|---|
| P/E Ratio | 39.10 | — |
| Price / Book | 30.33 | 70.01 |
| Price / Sales | 12.90 | 30.05 |
LLY leads on 2 of 2 valuation factors.
Profitability
| LLY | RYTM | |
|---|---|---|
| Net Margin | 33.53% | -85.59% |
| Return on Equity | 78.84% | -199.40% |
LLY leads on 2 of 2 profitability factors.
Dividend
| LLY | RYTM | |
|---|---|---|
| Dividend Yield | 0.59% | — |
| Payout Ratio | 23.23 | — |
LLY and RYTM split the dividend factors evenly.
Risk & Sentiment
| LLY | RYTM | |
|---|---|---|
| Short Interest | 1.29% | 1.12% |
RYTM leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, RYTM overview, RYTM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.